PubMed
pubmed.ncbi.nlm.nih.gov › 39569781
[Objective structural and functional monitoring of polypeptide retinal neuroprotective therapy in diabetic retinopathy] - PubMed
In recent years, there has been a growing interest in the contribution of neuroretinal degeneration to the pathogenesis of diabetic retinopathy (DR), preceding the classic vascular changes associated with DR. Purpose: This study evaluated the impact of the polypeptide drug Retinalamin on the ...
ResearchGate
researchgate.net › publication › 297874200_Use_of_Retinalamin_at_an_Early_Stage_of_Treatment_of_Non-proliferative_Diabetic_Retinopathy_in_Children_with_Type_1_Diabetes_Mellitus
Use of Retinalamin at an Early Stage of Treatment of Non-proliferative Diabetic Retinopathy in Children with Type 1 Diabetes Mellitus
September 1, 2011 - The aim of the work is to study the effect of retinalamin on circulatory dynamics and functional state of the retina when treating non-proliferative diabetic retinopathy in children with insulin dependent diabetes mellitus. Materials and Methods. There were included into the study 100 children with signs of diabetic retinopathy: microhemorrhages, capillary network distention.
Has anyone used the peptide Retilanamin for macular ...
Drug Regenerates Retina and Restores Vision in Blind Mice | The PROX1 protein hidden in our eyes may be the reason we can't repair lost vison.
At the end of the article it is suggested that a similar treatment might be used for brain and spinal cord injuries. If so this might be one of the most significant discoveries in history. More on reddit.com
52
3086
April 23, 2025Will it be obvious?
You are already aware of the changes in your vision, it won't be immediately obvious to others. I started using a cane (at night only) back in 2004 when I was diagnosed & underwent mobility training. RP was in my family, my older brother has RP too, and my visual impairment was never diagnosed as anything other than myopia. No eye doctor had ever said "you might have RP" to me until that routine eye test in 2004. I was working in website development, when I noticed colleagues across the office were slightly out of focus. I went for a routine eye test and what I thought would be new glasses., turned into the beginning of my RP journey. I knew I had serious eye problems growing up and it caused me much anxiety, embarrassment and injury. I had night blindness and a high degree of colour blindness. To top all that, I also had severe myopia and astigmatism. Without glasses, I could barely see past 20cm, but I could read small print, thread needles, draw, use a computer with zero accessibility and to the untrained eye, I didn't look blind! 20 years later, things are drastically different. I carry the cane day and night. It's obvious to anyone with relatively useful eyesight, that I have a severe sight impairment. My eyes have deteriorated to a point my previously thought impossible, I'd never dreamed my eyes would be as bad as they are today. It's almost as bad in the daytime, as it is at night time. I have a very narrow field of view, a high degree of colour blindness, I need support from friends and family if I'm going anywhere unfamiliat. I have tried to hold onto as much of my independence as possible, but as I've got an older, I've had to let other people help. Strap yourself in, RP is a very bumpy ride. More on reddit.com
14
14
December 12, 2024Study: Retinal “sweet spot” for myopia treatment
CosmicNootropic
cosmicnootropic.com › home › retinalamin®
Buy RETINALAMIN® - International shipping
Buy RETINALAMIN® - International shipping
Buy Retinalamin eye protection agent | Protect the retina and stimulate regeneration processes | Competitive price and international shipping
Price $224.00
RxEli
rxeli.com › retinalamin® 5 mg, 10 ampoules (im/parabulbar injections) (expected back in stock by the end of may)
ᐈ Buy RETINALAMIN® 5 mg, 10 ampoules (IM/Parabulbar Injections) (EXPECTED BACK IN STOCK BY THE END OF MAY) Online • RxEli
RETINALAMIN® 5 mg, 10 ampoules (IM/Parabulbar Injections) (EXPECTED BACK IN STOCK BY THE END OF MAY)
What is Retinalamin®?Retinalamin® is a tissue repair stimulant used in the treatment of various eye conditions that affect the retina.This medication is a peptide-based compound derived from natural sources, specifically designed to protect and restore retinal cells.Retinalamin® is commonly prescribed to patients with diseases like glaucoma, diabetic retinopathy, and retinal dystrophy.It works by stimulating cell regeneration, improving eye tissue metabolism, and enhancing blood flow in the eyes.How does Retinalamin® work?Retinalamin® is a retinal tissue repair stimulant that promotes regenera
Price $230.00
NCBI
ncbi.nlm.nih.gov › pmc › articles › PMC3380120
Retinoid Metabolism and Diabetes Mellitus - PMC
June 14, 2012 - Most previous studies on retinoid metabolism have focused on its association with cancer, hematologic and dermatologic disorders. Given the special concern over the recent increase in the prevalence of diabetes worldwide, the role of retinoid metabolism on glucose metabolism and insulin resistance in the human body is of marked importance.
Kcretina
kcretina.com › retinal disease and diabetes
Retinal Disease and Diabetes | Retina Associates Kansas City
In this informative blog post, our physicians at Retina Associates in Lenexa, KS, discuss retinal disease and diabetes, including symptoms, risk factors, treatment, and prevention.
PubMed Central
pmc.ncbi.nlm.nih.gov › articles › PMC7310218
Checking your browser - reCAPTCHA
June 18, 2020 - Checking your browser before accessing pmc.ncbi.nlm.nih.gov · Click here if you are not automatically redirected after 5 seconds
IRIS
retinalscreenings.com › home › 4 benefits of retinal imaging
Retinal Imaging Benefits for Diabetic Patients - IRIS
March 16, 2026 - In fact, digital retinal imaging that seamlessly integrates into any EMR software is creating widespread change in eye health. With benefits for patients, care teams, and practices alike, retinal imaging helps efficiently diagnose eye conditions and disorders common among people with diabetes.
PubMed Central
pmc.ncbi.nlm.nih.gov › articles › PMC11898816
Diabetic Retinopathy (DR): Mechanisms, Current Therapies ...
Checking your browser before accessing pmc.ncbi.nlm.nih.gov · Click here if you are not automatically redirected after 5 seconds
Nature
nature.com › nature reviews disease primers › primers › article
Diabetic retinopathy | Nature Reviews Disease Primers
March 17, 2016 - Diabetic retinopathy is a common microvascular complication of diabetes and is a major cause of vision loss in middle-aged and elderly people. In this Primer, Wong et al. discuss the epidemiology, underlying pathophysiological mechanisms, ...
New England Journal of Medicine
nejm.org › doi › full › 10.1056 › NEJMra1005073
Diabetic Retinopathy | New England Journal of Medicine
The incidence of diabetes is increasing, but that of diabetic retinopathy is falling, probably owing to better management of glucose levels, lipid abnormalities, and hypertension. Clinical trials o...
Retinaconsultantstexas
retinaconsultantstexas.com › blog › the-link-between-diabetes-and-retinal-health-what-s-beyond-retinopathy
The Link Between Diabetes and Retinal Health: What’s Beyond Retinopathy? | Retina Consultants of Texas
March 1, 2025 - Retinal Vein Occlusion: This occurs ... blindness. High blood sugar and high blood pressure—both common in diabetes—damage blood vessels, making them more prone to clotting and increasing the risk of this condition....
Optometry Times
optometrytimes.com › home › clinical › diabetic eye disease › do diabetes, diabetic retinal disease contribute to macular degeneration?
Do diabetes, diabetic retinal disease contribute to macular degeneration? | Optometry Times - Clinical News & Expert Optometrist Insights
May 10, 2026 - These disorders account for most of the vision loss in working-age and elderly Americans. ... age-related macular degeneration (AMD) has been suggested in multiple observational studies. Any connection is significant, of course, because diabetes is the leading cause of new vision loss in Americans aged 18-74 (often categorized as “working age”)1 and AMD is the leading cause of vision loss in adults aged 65 and above.2 Additionally, any common, underlying pathobiology might suggest interventions that could have profound public health implications.
PubMed Central
pmc.ncbi.nlm.nih.gov › articles › PMC10836695
Associations between serum retinol and all-cause mortality among adults with prediabetes and diabetes: A cohort study - PMC
Among participants with diabetes, compared to serum retinol levels of 50–60 μg/dL, the hazard ratio (HR) (95% confidence interval [CI]) of mortality was 1.25 (95% CI 0.96 to 1.62) and 1.21 (95% CI 0.91 to 1.62) for serum retinol <50 or ≥80 μg/dL, respectively.
ScienceDirect
sciencedirect.com › science › article › pii › S0928098725003057
Diabetic retinopathy in focus: Update on treatment advances, pharmaceutical approaches, and new technologies - ScienceDirect
October 1, 2025 - The proper functioning of neurons relies on a complex interplay among retinal cells, including the establishment of the blood-retinal barrier. Unfortunately, diabetes mellitus disrupts this dynamic system, disturbing normal cell-to-cell interactions and resulting in significant vascular abnormalities, loss of the blood-retinal barrier, and impaired neuronal function (Antonetti et al., 2021).
BMJ Best Practice
bestpractice.bmj.com › topics › en-us › 532
Diabetic retinopathy - Symptoms, diagnosis and treatment | BMJ Best Practice US
Sight-threatening features include diabetic macular edema, retinal ischemia, neovascularization of the retina or optic disc, neovascular glaucoma, vitreous hemorrhage, and tractional retinal detachment.
CDC
cdc.gov › diabetes › diabetes-complications › diabetes-and-vision-loss.html
Vision Loss and Diabetes | Diabetes | CDC
June 10, 2024 - Diabetic retinopathy (DR) is the leading cause of blindness in working-age adults. DR is when high blood sugar damages blood vessels in the retina (a part of your eye). Damaged blood vessels can swell and leak, causing blurry vision.
Mayo Clinic
mayoclinic.org › diseases-conditions › diabetic-retinopathy › diagnosis-treatment › drc-20371617
At risk of diabetes-related vision loss?-Diabetic retinopathy - Diagnosis & treatment - Mayo Clinic
August 13, 2025 - If you have proliferative diabetic retinopathy, you'll need treatment. Macular edema is often treated as well, but your retina specialist helps guide the best time to treat. Depending on the specific problems with your retina, options might include: Eye injections. These medicines, called vascular endothelial growth factor inhibitors, are injected into the fluid in the center of your eye, called the vitreous. The medicines help stop the growth of new blood vessels and decrease fluid buildup.
PubMed Central
pmc.ncbi.nlm.nih.gov › articles › PMC10177610
Retinal Cell Damage in Diabetic Retinopathy - PMC - NIH
This review provides an overview of DR and the structural and functional changes associated with DR, and discusses neuronal degeneration during diabetic retinopathy, the mechanisms underlying retinal neurodegeneration and microvascular complications, and perspectives on current and future clinic therapies.